How to Transition Smoothly — and Keep Losing Weight
Bridging the Gap: Life After Semaglutide (Part 3)
Why Transitioning Properly Matters
Many patients are now moving off compounded semaglutide or tirzepatide and beginning new protocols using liraglutideor dulaglutide.
While these GLP-1 medications are still effective for some patients, they often lead to:
-
Hunger returning
-
Cravings resurfacing
-
Slower or stalled fat loss
-
Weight regain if not properly supported
A smooth transition isn’t just about medication — it’s about restoring full metabolic support. That’s where SLM+ comes in.
🔁 3-Step Transition Plan
✅ Step 1: Restart GLP-1 at the Appropriate Dose
Whether you’re starting liraglutide (daily) or dulaglutide (weekly), begin with conservative titration — especially if there’s been a gap in therapy.
If switching to:
Liraglutide (Saxenda®, Victoza®, Compounded):
-
Start at 0.6 mg daily for 1 week
-
Increase weekly to 1.2 → 1.8 → 2.4 → 3.0 mg, as tolerated
-
Goal dose: 3.0 mg/day
If switching to:
Dulaglutide (Trulicity®, Compounded):
-
Start at 0.75 mg weekly
-
Increase to 1.5 → 3.0 → 4.5 mg, as tolerated
-
Goal dose: 4.5 mg weekly (based on patient response)
📌 Titrate slower for GI sensitivity or older patients
✅ Step 2: Add SLM+ for Metabolic Support
SLM+ is a science-backed supplement designed to enhance GLP-1 therapy — especially for legacy GLP-1s like liraglutide and dulaglutide that lack multi-hormonal support.
It provides:
-
Berberine HCl – Improves insulin sensitivity
-
Banaba Leaf Extract – Reduces post-meal glucose and insulin spikes
-
Bitter Melon – Mimics GIP-like effects for appetite, energy, and metabolism
🧪 Why Add SLM+?
These GLP-1s do not support:
-
GIP (fat metabolism & insulin synergy)
-
Amylin (satiety & glucagon suppression)
🔑 SLM+ helps mimic this hormonal support — and fills the gap left by newer drugs like semaglutide and tirzepatide.
Suggested Dosing for SLM+:
✅ Step 3: Track Progress, Adjust, and Stay Consistent
Most patients can still lose 10–13% of body weight with liraglutide when SLM+ is included.
Track Weekly:
-
Weight
-
Waist circumference
-
Energy / cravings
-
GI symptoms
-
Adherence to both GLP-1 + SLM+
Plateau Strategy:
-
Review meal frequency / composition
-
Ensure SLM+ and GLP-1 are taken consistently
-
Consider adding pramlintide for additional amylin support (see GPS Protocol)
-
Discuss with your provider
What You Can Expect with This Approach
✅ SLM+ helps liraglutide and dulaglutide function more like modern incretin-based therapies — without the cost or unavailability.
Summary: Protect the Progress You’ve Made
“Switching to an older GLP-1 doesn’t have to mean losing results. With the right support, you can stay on track — or even accelerate your progress.”
🔹 Add SLM+
🔹 Follow a structured titration
🔹 Stay consistent, track weekly, and course-correct if needed
Next Steps
✅ Order SLM+ now — fast shipping + provider support
✅ Download the GPS-L and GPS-D protocols
✅ Sign up for clinic or wholesale access
Medical Disclaimer: This blog is for informational purposes only and is not intended as medical advice. Always consult your healthcare provider before making any changes to your medications, supplements, or health regimen. Individual results may vary.
Supplement Disclaimer: Statements regarding dietary supplements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
Research & Innovation Disclosure: STAAR LABS conducts protocol development in collaboration with licensed providers and pharmacies. Our research focuses on combining nutraceutical and pharmaceutical interventions to enhance metabolic outcomes. Weight loss projections involving SLM+ are based on early observational feedback and theoretical mechanisms, not yet published in peer-reviewed clinical trials.
Pharmacy and Provider Disclaimer: STAAR LABS is not a licensed pharmacy, medical provider, or drug manufacturer. We do not dispense, prescribe, or sell prescription medications. All content is provided for informational and educational purposes only. Patients should consult their licensed healthcare provider or pharmacy before making any changes to their treatment plan.
